Upfront dose reduction of chemotherapy in older patients with metastatic colorectal cancer may reduce the number of severe side effects of chemotherapy and thus improve quality of life. Dr. Nienke de Glas and her team have received funding from the Dutch Cancer Society (KWF) to investigate dose-reduced chemotherapy in a randomized trial that will be enrolled in 40 Dutch hospitals.
In the Netherlands, more than half of the patients diagnosed with metastatic colorectal cancer are 70 years or older. [...]